Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy

BACKGROUND AND PURPOSE: Cannabis has been used to treat epilepsy for millennia, with such use validated by regulatory approval of cannabidiol (CBD) for Dravet syndrome. Unregulated artisanal cannabis‐based products used to treat children with intractable epilepsies often contain relatively low doses...

Descripción completa

Detalles Bibliográficos
Autores principales: Anderson, Lyndsey L., Heblinski, Marika, Absalom, Nathan L., Hawkins, Nicole A., Bowen, Michael T., Benson, Melissa J., Zhang, Fan, Bahceci, Dilara, Doohan, Peter T., Chebib, Mary, McGregor, Iain S., Kearney, Jennifer A., Arnold, Jonathon C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292928/
https://www.ncbi.nlm.nih.gov/pubmed/34384142
http://dx.doi.org/10.1111/bph.15661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292928/
https://www.ncbi.nlm.nih.gov/pubmed/34384142
http://dx.doi.org/10.1111/bph.15661

Ejemplares similares